Skip to main content
. 2015 Jul 8;12(4):4837–4842. doi: 10.3892/mmr.2015.4058

Figure 2.

Figure 2

Kaplan-Meier curves of survival durations in patients with renal carcinoma, according to the expression levels of TET1. *P<0.05, compared with the high TET1 expression group.